GlassScriptPhysician profile
Kevin C Lingle
NPI 1558553552
$4,164.00
in general payments reported to CMS, 2019-2025
28 companies · $701 in 2025
The $701 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $231 · 2021: $293 · 2022: $655 · 2023: $968 · 2024: $697 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,365.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $707.67 | 2019-2025 | Coroflow, Xience Skypoint, Supera |
| Irhythm Technologies, INC. | $467.77 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Inari Medical, INC. | $410.70 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $381.05 | 2019-2025 | Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor, General - Ep |
| Novartis Pharmaceuticals Corporation | $312.64 | 2019-2023 | |
| Medtronic, INC. | $250.33 | 2023-2025 | Symplicity G3, Onyx Frontier |
| Shockwave Medical, INC | $248.39 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.04 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $204.70 | 2019-2023 | Xarelto |
| Teleflex LLC | $119.89 | 2022-2024 | Turnpike |
| Astrazeneca Pharmaceuticals LP | $118.77 | 2019-2022 | |
| Stryker Corporation | $117.49 | 2025 | Clottriever Bold Catheter |
| Medtronic Vascular, INC. | $102.25 | 2019-2020 | |
| Pfizer INC. | $60.01 | 2019-2023 | |
| Bardy Diagnostics, INC. | $58.53 | 2020-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $50.38 | 2023 | Exparel, Iovera |
| Novo Nordisk INC | $41.79 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.69 | 2019-2023 | |
| Livanova USA, INC. | $32.97 | 2020 | |
| Amgen INC. | $31.88 | 2019 | |
| Horizon Therapeutics Plc | $31.10 | 2019 | |
| Cardiovascular Systems INC. | $28.70 | 2020-2021 | |
| Cvrx, INC. | $27.89 | 2022 | |
| Bard Peripheral Vascular, INC. | $18.21 | 2021 | |
| Arbor Pharmaceuticals, INC. | $16.68 | 2019 | |
| Biocompatibles, INC. | $15.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.06 | 2021 | |
| Penumbra, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lingle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.